The latest price target for Bioceres Crop Solutions (NASDAQ:BIOX) was reported by Canaccord Genuity on November 13, 2024. The analyst firm set a price target for $9.50 expecting BIOX to rise to within 12 months (a possible 47.52% upside). 10 analyst firms have reported ratings in the last year.

The latest analyst rating for Bioceres Crop Solutions (NASDAQ:BIOX) was provided by Canaccord Genuity, and Bioceres Crop Solutions maintained their buy rating.

There is no last upgrade for Bioceres Crop Solutions

There is no last downgrade for Bioceres Crop Solutions.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bioceres Crop Solutions, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bioceres Crop Solutions was filed on November 13, 2024 so you should expect the next rating to be made available sometime around November 13, 2025.

While ratings are subjective and will change, the latest Bioceres Crop Solutions (BIOX) rating was a maintained with a price target of $10.00 to $9.50. The current price Bioceres Crop Solutions (BIOX) is trading at is $6.44, which is out of the analyst’s predicted range.